These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9018225)

  • 21. [Generalized changes in regional blood flow and microcirculation during the tumor growth].
    Natadze TG; Kipiani VA
    Patol Fiziol Eksp Ter; 1987; (5):8-16. PubMed ID: 3324029
    [No Abstract]   [Full Text] [Related]  

  • 22. SPARC-induced migration of glioblastoma cell lines via uPA-uPAR signaling and activation of small GTPase RhoA.
    Kunigal S; Gondi CS; Gujrati M; Lakka SS; Dinh DH; Olivero WC; Rao JS
    Int J Oncol; 2006 Dec; 29(6):1349-57. PubMed ID: 17088972
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transcriptional upregulation of SPARC, in response to c-Jun overexpression, contributes to increased motility and invasion of MCF7 breast cancer cells.
    Briggs J; Chamboredon S; Castellazzi M; Kerry JA; Bos TJ
    Oncogene; 2002 Oct; 21(46):7077-91. PubMed ID: 12370830
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Absence of SPARC in murine lens epithelium leads to increased deposition of laminin-1 in lens capsule.
    Yan Q; Perdue N; Blake D; Sage EH
    Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4652-60. PubMed ID: 16303962
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Link between tumor progression, proteases, and cell motility. Pathology B workshop.
    Muschel RJ; Tykocinski M; Padarathsingh M
    Am J Pathol; 1996 Sep; 149(3):1073-6. PubMed ID: 8780409
    [No Abstract]   [Full Text] [Related]  

  • 26. Secreted protein acidic and rich in cysteine functions in colitis via IL17A regulation in mucosal CD4
    Tanaka M; Takagi T; Naito Y; Uchiyama K; Hotta Y; Toyokawa Y; Ushiroda C; Hirai Y; Aoi W; Higashimura Y; Mizushima K; Okayama T; Katada K; Kamada K; Ishikawa T; Handa O; Itoh Y
    J Gastroenterol Hepatol; 2018 Mar; 33(3):671-680. PubMed ID: 28582593
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Angiogenesis and apoptosis are cellular parameters of neoplastic progression in transgenic mouse models of tumorigenesis.
    Bergers G; Hanahan D; Coussens LM
    Int J Dev Biol; 1998; 42(7):995-1002. PubMed ID: 9853830
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential effects of SPARC and cationic SPARC peptides on DNA synthesis by endothelial cells and fibroblasts.
    Funk SE; Sage EH
    J Cell Physiol; 1993 Jan; 154(1):53-63. PubMed ID: 8419407
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SPARC deficiency leads to early-onset cataractogenesis.
    Norose K; Clark JI; Syed NA; Basu A; Heber-Katz E; Sage EH; Howe CC
    Invest Ophthalmol Vis Sci; 1998 Dec; 39(13):2674-80. PubMed ID: 9856777
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SPARC is dispensable for murine hematopoiesis, despite its suspected pathophysiological role in 5q-myelodysplastic syndrome.
    Siva K; Jaako P; Miharada K; Rörby E; Ehinger M; Karlsson G; Karlsson S
    Leukemia; 2012 Nov; 26(11):2416-9. PubMed ID: 22475871
    [No Abstract]   [Full Text] [Related]  

  • 31. SPARC (osteonectin) in breast tumors of different histologic types and its role in the outcome of invasive ductal carcinoma.
    Hsiao YH; Lien HC; Hwa HL; Kuo WH; Chang KJ; Hsieh FJ
    Breast J; 2010; 16(3):305-8. PubMed ID: 20210803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mice deficient for the secreted glycoprotein SPARC/osteonectin/BM40 develop normally but show severe age-onset cataract formation and disruption of the lens.
    Gilmour DT; Lyon GJ; Carlton MB; Sanes JR; Cunningham JM; Anderson JR; Hogan BL; Evans MJ; Colledge WH
    EMBO J; 1998 Apr; 17(7):1860-70. PubMed ID: 9524110
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The role of SPARC gene in tumorigenic capacity of human melanoma cells].
    Ledda MF; Adris S; Bover L; Bravo AL; Mordoh J; Podhajcer OL
    Medicina (B Aires); 1996; 56(1):51-4. PubMed ID: 8734932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SPARC expression is associated with impaired tumor growth, inhibited angiogenesis and changes in the extracellular matrix.
    Chlenski A; Liu S; Guerrero LJ; Yang Q; Tian Y; Salwen HR; Zage P; Cohn SL
    Int J Cancer; 2006 Jan; 118(2):310-6. PubMed ID: 16052522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of SPARC--matricellular protein in pathophysiology and tissue injury healing. Implications for gastritis and gastric ulcers.
    Phan E; Ahluwalia A; Tarnawski AS
    Med Sci Monit; 2007 Feb; 13(2):RA25-30. PubMed ID: 17261993
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [SPARC and malignant neoplasms].
    Cui Y; Wang TY
    Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(9):642-4. PubMed ID: 15949367
    [No Abstract]   [Full Text] [Related]  

  • 37. Survey of mechanisms in electrochemical treatment (ECT) of cancer.
    Nordenström BE
    Eur J Surg Suppl; 1994; (574):93-109. PubMed ID: 7531033
    [No Abstract]   [Full Text] [Related]  

  • 38. SPARC, a secreted protein associated with morphogenesis and tissue remodeling, induces expression of metalloproteinases in fibroblasts through a novel extracellular matrix-dependent pathway.
    Tremble PM; Lane TF; Sage EH; Werb Z
    J Cell Biol; 1993 Jun; 121(6):1433-44. PubMed ID: 8509459
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional mapping of SPARC: peptides from two distinct Ca+(+)-binding sites modulate cell shape.
    Lane TF; Sage EH
    J Cell Biol; 1990 Dec; 111(6 Pt 2):3065-76. PubMed ID: 2269665
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Developmental anomalies of Xenopus embryos following microinjection of SPARC antibodies.
    Purcell L; Gruia-Gray J; Scanga S; Ringuette M
    J Exp Zool; 1993 Feb; 265(2):153-64. PubMed ID: 8423439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.